StreetAccount Metrics Recap - BeOne Medicines Q1 Earnings ($241.75, 0.00)
BeOne Medicines reports Q1 adjusted EPADS $1.22 ($241.75, 0.00)
StreetAccount Summary - Trading higher/lower: Asia mid-morning
StreetAccount Summary - Trading higher/lower: Hong Kong mid-morning
StreetAccount Consensus Metrics Preview - BeOne Medicines Q1 Earnings ($255.77, 0.00)
Powered by FactSet Research Systems Inc.